Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Robarts Research Institute, |
RCV000660698 | SCV000782878 | uncertain significance | Hypercholesterolemia, familial, 1 | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004026063 | SCV003531380 | uncertain significance | Cardiovascular phenotype | 2023-04-13 | criteria provided, single submitter | clinical testing | The p.E2315K variant (also known as c.6943G>A), located in coding exon 26 of the APOB gene, results from a G to A substitution at nucleotide position 6943. The glutamic acid at codon 2315 is replaced by lysine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |